FDA Recall Terminated

Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens.

Recall: Z-0556-2016 · Initiated November 23, 2015

Recall

Recall Number
Z-0556-2016
Event Number
72760
Firm
Biomerieux Inc
FEI Number
1950204
Product Code
NJR
Status
Terminated
Root Cause
No Marketing Application
Initiated
November 23, 2015
Posted
December 29, 2015
Terminated
February 24, 2016
Address
595 Anglum Rd, Hazelwood, MO, 63042-2320

Description

Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens.

Reason

FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.

Action

The firm, Biomerieux, sent an "Urgent Product Removal Notice" dated November 23, 2015 to its consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to confirm that the letter has been distributed and reviewed by all appropriate personnel, discontinue and discard any remaining inventory, store letter with your bioMerieux documentation and complete the attached Acknowledgement Form via fax to: (919) 620-3306 attention of: bioMerieux NA ComOps QA/RA. If you have any questions or concerns, please contact your local bioMrieux Clinical Customer Service organization at (800) 682-2666.

Distribution

US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.

Quantity

24 cartons